Author Guidelines

1. About the Journal

Jurnal Keperawatan Suaka Insan (JKSI) publishes original scholarly work relevant to nursing and health sciences, including clinical, community, and educational nursing practice. JKSI is committed to editorial standards consistent with the International Committee of Medical Journal Editors (ICMJE) Recommendations, the Committee on Publication Ethics (COPE) guidance, and the reporting standards maintained by the EQUATOR Network.

1.1 Aims and Scope

JKSI welcomes manuscripts addressing nursing science, clinical nursing practice, community and public health nursing, nursing education, nursing management, and related health disciplines, using quantitative, qualitative, or mixed-methods approaches.

1.2 Article Types

Each article type follows its own reporting structure, described in Section 3. Authors should select the manuscript template that corresponds to their article type.

1.3 Target Readership

Nurses, nursing students, nurse educators, other health professionals, and researchers with an interest in nursing and health-related evidence.

2. Before Submission

2.1 Originality and Exclusivity

Manuscripts submitted to JKSI must be original, must not have been published previously in any language, and must not be under consideration by another journal. Authors must disclose any closely related manuscripts that have been submitted or published elsewhere.

2.2 Preprints

Manuscripts previously posted on a recognized preprint server may be considered for submission, provided that the preprint is disclosed at the time of submission, the preprint server and version are cited, and the preprint is not itself under review at another journal.

2.3 Authorship

Authorship should be limited to individuals who have made a substantial contribution to the work and who meet all four of the following ICMJE authorship criteria:

  1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data;
  2. Drafting the work or revising it critically for important intellectual content;
  3. Final approval of the version to be published;
  4. Agreement to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All individuals meeting these four criteria should be listed as authors, and all who meet them must be listed. Individuals who contributed but do not meet all four criteria should be recognized in the Acknowledgments section instead. The determination of who qualifies as an author is the responsibility of the authors themselves, not of the Editor.

Authorship Changes

Any addition, removal, or reordering of authors after submission requires a written explanation and signed consent from all authors (including any author being removed or added), and is subject to approval by the Editor-in-Chief. Undisclosed changes to authorship, gift authorship, guest authorship, and ghost authorship are considered research misconduct and will be handled according to COPE guidance.

2.4 Ethical Approval

For studies involving human participants or animals, authors must state, in the Methods section, the name of the approving research ethics committee or institutional review board and the approval or reference number. Where formal ethical approval was not required (for example, for certain secondary analyses of publicly available, de-identified data), authors must provide a clear statement explaining why approval was not needed. Research involving human participants must have been conducted in accordance with the Declaration of Helsinki; research involving animals must comply with applicable institutional and national guidelines for animal research.

2.5 Informed Consent

Authors must state how informed consent was obtained from participants (or their legal guardians/representatives, for vulnerable populations, minors, or participants unable to consent). Where a case report or figure includes information or images that could identify a participant or patient, authors must obtain and retain written consent for publication and state this explicitly in the manuscript.

2.6 Clinical Trial Registration

Clinical trials should be prospectively registered in a recognized public trial registry (for example, ClinicalTrials.gov or the WHO International Clinical Trials Registry Platform). The registry name and registration number must be reported in the manuscript's abstract and Methods section.

2.7 Required Submission Documents

  • Manuscript file, prepared using the appropriate JKSI Manuscript Template
  • Title page (author names, affiliations, corresponding author details — see Section 5.2)
  • Conflict of Interest / Author's Statement form, signed by all authors
  • Copy of ethical approval, or a documented justification for its absence (Section 2.4)
  • Completed Submission A physically signed submission checklist is not required. Authors only need to verify and tick the mandatory checklist boxes electronically during the submission process in the Open Journal Systems (OJS). Please ensure all required documents (Title Page, Main Manuscript, Conflict of Interest Form, and Ethical Approval) are ready before proceeding.
  • Completed reporting-guideline checklist appropriate to the study design (Section 4),

 

3. Article Types and Manuscript Structure

Each article type has a distinct structure. Authors should not attempt to adapt one structure to a different article type.

3.1 Original Research (Quantitative)

Quantitative original research follows the IMRAD structure:

  • Introduction
  • Methods
  • Results
  • Discussion
  • Limitations
  • Conclusion

Subheadings within Methods and Discussion are encouraged (see Sections 5.6 and 5.8) to help reviewers evaluate completeness. The applicable reporting guideline (Section 4) must be followed.

3.2 Qualitative Research

Qualitative research follows a flexible structure appropriate to the qualitative tradition used (e.g., phenomenology, grounded theory, ethnography, qualitative description), while still following COREQ or SRQR reporting standards (Section 4). At minimum, the manuscript should address:

  • Philosophical or epistemological orientation, where relevant
  • Qualitative approach and rationale for its use
  • Researcher positionality and reflexivity
  • Sampling strategy and participant characteristics
  • Rationale for sample size (e.g., data saturation or information power)
  • Data collection procedure (e.g., interview guide, setting, duration)
  • Transcription and coding procedures
  • Analytic framework
  • Strategies used to establish trustworthiness (credibility, dependability, confirmability, transferability).

3.3 Systematic Review

Systematic reviews (with or without meta-analysis) must follow PRISMA 2020 and, where applicable, relevant PRISMA extensions (e.g., PRISMA-ScR for scoping reviews, PRISMA-P for protocols). The manuscript should include a PRISMA flow diagram and the completed PRISMA 2020 checklist as a supplementary file. Where the review protocol was registered (e.g., PROSPERO), the registration number must be reported.

3.4 Case Report

Case reports must follow the CARE (CAse REport) guideline and should include:

  • Title identifying the article as a case report
  • Structured abstract (Background, Case presentation, Conclusion)
  • Patient information (de-identified)
  • Clinical findings
  • Timeline of the case
  • Diagnostic assessment
  • Therapeutic intervention
  • Follow-up and outcomes
  • Patient perspective, where relevant and available
  • A statement confirming informed consent for publication

The completed CARE checklist must be submitted as a supplementary file.

4. Reporting Guidelines

Authors are required to use the reporting guideline appropriate to their study design and to submit the completed checklist as a supplementary file at submission. This is a mandatory requirement, not a recommendation.

Study Design

Required Reporting Guideline

Cross-sectional study

STROBE

Cohort study

STROBE

Case-control study

STROBE

Randomized controlled trial

CONSORT

Quasi-experimental / non-randomized intervention

TREND

Qualitative research (interviews, focus groups)

COREQ or SRQR

Mixed-methods research

Appropriate combination of guidelines for each component (e.g., STROBE + COREQ), plus GRAMMS where relevant

Systematic review / meta-analysis

PRISMA 2020

Scoping review

PRISMA-ScR

Systematic review or trial protocol

PRISMA-P or SPIRIT

Diagnostic accuracy study

STARD

Case report

CARE

 

Authors are encouraged to consult the EQUATOR Network (www.equator-network.org) for the current version of each guideline and for study designs not listed above. Where a study combines methods or does not fit neatly into one category, authors should identify and justify the most appropriate guideline(s) in their cover letter.

5. Manuscript Preparation

5.1 General Format

Manuscripts should be prepared using the JKSI Manuscript Template and its built-in paragraph styles (JKSI Title, JKSI Author, JKSI Heading 1, JKSI Heading 2, JKSI Body, JKSI Table Caption, JKSI Figure Caption, JKSI Reference). Authors should apply these styles rather than manually formatting text, and should not include layout instructions (e.g., blank-line or font-size notes) in the submitted manuscript.

Manuscripts should contain approximately 3,500–4,500 words, excluding the abstract, references, tables, and figure legends, normally spanning 6–10 pages when formatted in the JKSI template. Word count, not page count, is the primary standard, since page count depends heavily on tables, figures, and layout.

All manuscripts must be written exclusively in English. Authors are strongly encouraged to have their manuscripts professionally proofread prior to submission to ensure accurate scientific English. Manuscripts with substantial linguistic deficiencies may be returned for revision or rejected.

5.2 Title Page

Submitted as a separate file or a clearly separable section, the title page should contain:

  • Full article title (concise, without abbreviations, maximum 20 words)
  • Full names of all authors, without academic titles, in the intended publication order
  • Each author's affiliation (department and institution)
  • ORCID iD for each author (strongly encouraged)
  • Corresponding author's name, mailing address, telephone number, and email address
  • A short running title (maximum 40 characters, including letters and spaces)
  • Total word count of the manuscript text
  • Any disclaimers, where applicable

5.3 Abstract

For original research, the abstract must be structured and must not exceed 250 words, using the following headings:

  • Background
  • Objective
  • Methods
  • Results
  • Conclusion

For qualitative research, the Results heading may be replaced with "Findings" and should summarize the approach, sample, analytic method, and major themes. For systematic reviews, follow the PRISMA 2020 structured-abstract format. For case reports, use Background, Case Presentation, and Conclusion.

The abstract must not contain citations. Recommendations or implications should not be treated as a mandatory abstract component; they may be included briefly within the Conclusion if space allows. For quantitative studies, authors are encouraged to report effect estimates with 95% confidence intervals in the abstract rather than p-values alone. The abstract must be provided in both English and Bahasa Indonesia.

5.4 Keywords

Provide 3–5 keywords or short phrases, in English, suitable for indexing. Where possible, use terms from a controlled vocabulary such as MeSH.

5.5 Introduction

State the background and rationale for the study, the relevant existing evidence, and the specific objective(s) or hypothesis being addressed. Avoid a detailed literature review; reserve interpretation of findings for the Discussion.

5.6 Methods

Methods must be described in sufficient detail to permit replication. Subheadings are encouraged. Minimum required content differs by study type:

Quantitative Studies

  • Study design
  • Study setting and timeframe
  • Population and eligibility (inclusion/exclusion) criteria
  • Sample size determination
  • Sampling technique
  • Variables and their operational definitions
  • Instruments, including validity and reliability evidence
  • Data collection procedure
  • Approach to bias and confounding
  • Statistical analysis, including software used
  • Handling of missing data
  • Ethical approval and consent procedures (may cross-reference Section 2.4–2.5)

Qualitative Studies

See Section 3.2 for the minimum required content specific to qualitative methods.

5.7 Results

Present results in logical order, in text, tables, and figures, without duplicating the same data across formats. Citations should generally be avoided in the Results section unless necessary to identify previously established instruments, datasets, definitions, or analytical procedures. Report numerical results with appropriate precision and, for quantitative comparisons, with effect estimates and 95% confidence intervals rather than p-values alone (see Section 7).

5.8 Discussion

The Discussion should be organized to address:

  • Principal findings
  • Interpretation of findings
  • Comparison with previous evidence
  • Possible mechanisms or explanations
  • Clinical, educational, or community implications
  • Strengths of the study
  • Implications for future research

The Discussion should not restate the Results in detail, and the Conclusion should not be embedded as the final sentence of the Discussion; Conclusion is a separate, labeled section (Section 5.10).

5.9 Limitations

Present study limitations as a distinct subsection or section. Authors should explain how each limitation could plausibly affect internal validity, external validity, measurement, interpretation, or generalizability, rather than listing limitations without explanation.

Not recommended: "The study was limited by the small sample size."

Recommended: "The relatively small sample size may have reduced the precision of the effect estimates and limits generalizability to similar community health-center settings."

5.10 Conclusion

State the principal conclusion(s) supported directly by the study's findings, avoiding claims not warranted by the data. The Conclusion is presented as its own labeled section, separate from the Discussion.

5.11 Acknowledgments

Acknowledge individuals who contributed to the work but do not meet the authorship criteria in Section 2.3 (e.g., technical assistance, general supervisory support), with their permission.

5.12 Funding

State the source(s) of financial support for the research, including grant numbers, or state that no funding was received. Describe the role, if any, of the funder in the study design, data collection, analysis, interpretation, or decision to publish.

Example: "This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."

5.13 Conflict of Interest

Authors must declare any financial or non-financial interests that could be perceived to influence the work. Each author must submit a completed ICMJE Disclosure of Interest form at submission (See the submission preparation check list).

Example: "The authors declare no conflict of interest."

5.14 Data Availability

Authors must include a Data Availability Statement describing whether, and how, the underlying data can be accessed.

Example: "The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request."

Example: "The data are not publicly available because they contain information that could compromise participant privacy."

5.15 CRediT Author Statement

All authors must provide a CRediT (Contributor Roles Taxonomy) statement identifying each author's contribution(s), using the standard CRediT roles (e.g., Conceptualization, Methodology, Formal analysis, Writing-original draft, Writing-review & editing, Supervision). The corresponding author is responsible for the accuracy of the CRediT statement and for obtaining agreement from all co-authors. Requirements for authorship (Section 2.3) apply regardless of CRediT role. Please note that authors must carefully verify the list and order of authors before submission. Any changes to authorship including the addition, deletion, or rearrangement of author names, are strictly prohibited after the manuscript has been submitted.

5.16 References

See Section 8.

6. Tables and Figures

6.1 Tables

Tables should be placed after the References, each on a separate page, and cited in numerical order in the text. Each table should have a brief, clear caption above it. Use Times New Roman, 10 pt, single-spaced. Tables should use minimal horizontal rules and no vertical lines. Identify statistical measures of variation (e.g., SD, SE). If data are reproduced from another source, obtain permission and acknowledge the source in a table footnote.

6.2 Figures

Figures should be submitted in JPEG, TIFF, or PNG format at a minimum resolution of 300 dpi, and, where possible, provided in an editable format (e.g., native chart data) rather than as a flattened image. Figures should be numbered consecutively in the order cited in the text, with a caption below each figure. As JKSI is a digital-first, open-access journal, there is no separate charge or restriction for color figures.

Photographs or images of potentially identifiable individuals must be accompanied by written consent for publication (see Section 2.5). If a figure has been published previously, authors must acknowledge the original source and provide written permission from the copyright holder.

6.3 Units of Measurement

Use SI (International System) units. Temperatures should be reported in degrees Celsius; blood pressure in millimeters of mercury (mmHg). Drug concentrations may be reported in SI or mass units, with the alternative provided in parentheses where useful.

7. Statistical Reporting

All statistical methods must be described in sufficient detail in the Methods section to allow a knowledgeable reader to verify the reported results. Specify the statistical software (including version) used.

Authors should report effect estimates together with an appropriate measure of uncertainty, such as a 95% confidence interval, wherever applicable. A p-value alone should not be reported as the sole indicator of the importance of a finding.

  • Mean difference with 95% CI
  • Odds ratio (OR) with 95% CI
  • Risk ratio (RR) with 95% CI
  • Regression coefficient with 95% CI
  • Correlation coefficient with 95% CI, where available

Report exact p-values (e.g., p = 0.001) rather than only indicating significance, except where p is very small, in which case p < 0.001 may be used. Authors are encouraged to consult SAMPL (Statistical Analyses and Methods in the Published Literature) guidance, available via the EQUATOR Network, for further detail on statistical reporting.

8. References

JKSI uses APA 7th Edition (American Psychological Association) reference style. Authors should cite sufficient, relevant, and up-to-date references to support the rationale, methodology, interpretation, and conclusions of the manuscript, prioritizing recent primary research and authoritative sources. There is no fixed minimum or maximum number of references; the appropriate number varies by article type (systematic reviews, in particular, will typically require considerably more than 25).

For in-text citations, APA 7 uses "et al." for works with three or more authors from the first citation onward. Avoid citing abstracts as references. Manuscripts submitted but not yet accepted should be cited as "unpublished observations," with written permission from the source. Accepted-but-not-yet-published papers may be cited with the journal name and "Forthcoming." Avoid citing personal communications unless the information is essential and unavailable elsewhere; if used, name the person and date, and obtain written permission confirming accuracy.

Authors are encouraged to use reference management software such as Zotero, Mendeley, EndNote, or an equivalent tool, and to ensure that DOIs are included and rendered as clickable links where available.

Appendices

Appendices should be used only when necessary and placed after the references. Where there is more than one appendix, they should be ordered alphabetically.

9. Research and Publication Ethics

JKSI follows the Committee on Publication Ethics (COPE) guidance in handling all aspects of publication ethics, including allegations of research and publication misconduct.

9.1 Human and Animal Research

See Sections 2.4 and 2.5 for ethical approval and informed consent requirements.

9.2 Plagiarism and Duplicate Publication

JKSI screens submitted manuscripts for plagiarism, duplicate publication, and substantial textual overlap with previously published work. Manuscripts found to involve plagiarism or redundant publication may be rejected at any stage, and, if identified after publication, may be corrected or retracted in accordance with COPE guidance.

9.3 Image Manipulation

Images must not be manipulated in a way that creates a false impression of the underlying data. Adjustments to brightness, contrast, or color balance are acceptable only when applied equally across an entire image and clearly disclosed if they might affect interpretation.

9.4 Handling of Allegations

Allegations of misconduct relating to submitted or published work will be investigated in accordance with COPE flowcharts and guidance. Authors will be given the opportunity to respond before any editorial decision is finalized.

10. Use of Artificial Intelligence

As the landscape of scientific publishing evolves, Jurnal Keperawatan Suaka Insan (JKSI) is committed to maintaining the highest standards of integrity, transparency, and ethical conduct. Authors may use artificial intelligence (AI) tools for tasks such as language improvement, editing, translation, or literature searching. However, while AI can enhance efficiency and provide support in synthesizing literature, these tools must never replace human critical thinking, expertise, and professional judgment.

10.1. Authorship and Responsibilities

  • Authorship Prohibition: AI tools must not be listed as an author or co-author. Authorship implies legal and ethical responsibilities that can only be attributed to humans, in accordance with JKSI authorship requirements (Section 2.3).
  • Accountability and Originality: Authors remain fully responsible and accountable for the accuracy, comprehensiveness, originality, and integrity of the submitted manuscript. Authors must verify all facts, citations, and analyses generated or assisted by AI tools to ensure they are not fabricated or incorrect. The manuscript must reflect the authors' authentic analysis, interpretation, and insights.
  • Privacy and Rights: Authors must ensure that the use of AI tools does not violate data privacy, intellectual property, or other legal rights.

10.2. Mandatory Disclosure Statement If Generative AI or AI-assisted technologies have been used in manuscript preparation, data analysis, or content generation (excluding basic tools for grammar and spelling checks), authors must declare this upon submission.

  • Placement: The declaration must be included in a dedicated section titled "Declaration of Generative AI and AI-assisted Technologies in the Manuscript Preparation Process", located immediately before the References list.
  • Required Template: Authors must use the following phrasing:

"During the preparation of this work the author(s) used [NAME OF TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article."

  • Note: If no AI tools were used for content generation or analysis, no statement is required.

10.3. Policy on Images and Visual Media The integrity of scientific images is paramount. JKSI does not permit the use of AI to create or alter images in submitted manuscripts, subject to the following rules:

  • Prohibited Actions: It is strictly unacceptable to use AI to enhance, obscure, move, remove, or introduce specific features within an image.
  • Acceptable Adjustments: Standard adjustments to brightness, contrast, or color balance are permitted as long as they do not eliminate information present in the original image.
  • Research Design Exception: If AI-generated imagery is a fundamental part of the research design or methodology, authors must provide a comprehensive description of the tool (including version, model, and manufacturer) and a clear explanation of how it was used in the Methods section.

10.4. Confidentiality in Peer Review and Editorial Workflow To protect the confidentiality of research and the rights of authors, reviewers and editors are strictly prohibited from using generative AI or AI-assisted technologies (such as ChatGPT) to evaluate manuscripts or generate peer review reports. Uploading confidential manuscript content into non-secure, publicly available AI systems constitutes a breach of confidentiality. Editors may use specific, secure AI-based tools solely to support internal editorial workflows (e.g., plagiarism screening) and remain fully responsible for the final editorial decision.

10.5. Ethical Compliance Any use of AI that results in the fabrication of data, falsification of results, or plagiarism will be treated as scientific ethical abuse and will be managed strictly according to JKSI and COPE (Committee on Publication Ethics) ethical guidelines.

 

11. Peer Review Process

All manuscripts undergo an initial editorial screening (pre-review) conducted by the Editor-in-Chief to evaluate the manuscript’s scope, originality, and compliance with these Guidelines. This pre-review process typically takes 7 to 14 days. Manuscripts that pass this initial screening are then assigned to a Section Editor and sent for a double-blind peer review by at least two independent reviewers with relevant expertise. Reviewers' and authors' identities are concealed from one another throughout the review process.

The Editor-in-Chief makes the final decision based on reviewer recommendations, which may include: accept, minor revision, major revision, or reject. Authors are typically given a defined period to submit a revised manuscript together with a point-by-point response to reviewer comments.

11.1. Letter of Acceptance (LoA) Policy

The Management of Jurnal Keperawatan Suaka Insan (JKSI) enforces the following official guidelines regarding the issuance of the Letter of Acceptance (LoA):

  • Eligibility for LoA: The LoA is issued by the Editorial Board only after a manuscript has successfully passed the rigorous peer-review process, completed all required revisions, and been officially declared fit for publication.
  • Standard Procedure and Timeline: The workflow leading to the issuance of an LoA strictly follows these stages: Submission → Pre-Review by Editor-in-Chief (7-14 days) → Double-Blind Peer Review → Revision → Final Acceptance & LoA Issuance. The estimated timeframe for the issuance of an LoA is 2 to 3 months. Please note that this duration is flexible and highly dependent on the responsiveness of the reviewers and the quality of the revisions provided by the authors.
  • Validity of Document: A legitimate LoA issued by JKSI will contain the following elements: (1) Official Journal Letterhead, (2) Official Reference Number, (3) Complete Author Identity and Article Title, and (4) Signature of the Editor-in-Chief.
  • Editorial Independence: The LoA is issued solely based on the scientific merit and the results of our editorial process. JKSI strictly does not accommodate requests to expedite the issuance of an LoA for personal, administrative, or external reasons (e.g., graduation requirements, Yudisium, or academic examinations). The journal maintains complete editorial independence and has no administrative involvement in the academic deadlines or graduation processes of any institution.

 

12. Post-Publication Policies

12.1 Corrections (Erratum/Corrigendum)

Minor errors that do not affect the overall scientific interpretation or integrity of a published article may be corrected. This will be addressed through a formally published correction (erratum for publisher errors, or corrigendum for author errors) that is permanently linked to the original article.

12.2 Retractions

Articles found, after publication, to contain serious errors, fabricated or falsified data, plagiarism, or other significant violations of publication ethics will be retracted in accordance with the Committee on Publication Ethics (COPE) guidelines. A formal retraction notice will be permanently linked to the original article and will clearly state the reason for the retraction.

12.3 Expressions of Concern

In cases where an allegation of misconduct or severe data inaccuracy is under investigation and cannot be promptly resolved, JKSI may publish an Expression of Concern to alert readers, pending the final outcome of the official investigation.

12.4 Handling Procedure for Post-Publication Issues

To ensure fairness and transparency in addressing potential corrections, retractions, or expressions of concern, JKSI strictly follows this procedural workflow:

  1. Reporting: The editorial team receives a formal report or notification from authors, readers, or institutions regarding potential errors or ethical concerns in a published article.
  2. Investigation: The Editor-in-Chief, alongside assigned Section Editors, conducts a thorough initial investigation to assess the validity and severity of the report.
  3. Editorial Board Meeting: An official Editorial Board meeting is convened to carefully review the investigation findings and examine the evidence.
  4. Decision Making: Based on the review, the Editorial Board makes a final, binding decision on whether to issue a correction, an expression of concern, or a full retraction.
  5. Public Announcement: The final decision is officially enacted, and the corresponding notice is prominently published on the JKSI website and linked to the article record.

12.5 Appeals and Complaints

Authors who wish to appeal an editorial decision or to raise a complaint about the handling of their manuscript may write to the Editor-in-Chief. Appeals will be considered by an editor not previously involved in the original decision, where feasible. All appeals and complaints should be directed to the Jurnal Keperawatan Suaka Insan Secretariat via email at lppm@ikessi.ac.id, with carbon copies (CC) sent to lppmstikessuakainsan@gmail.com and mariafrani10@gmail.com.

 

13. Copyright, Licensing, and Archiving

Authors retain copyright of their published work and grant JKSI the right of first publication. Published articles are made available under the journal's open-access license, as stated on the journal website. Authors are responsible for obtaining permission to reproduce any third-party copyrighted material (e.g., previously published figures or tables) prior to submission.

For complete and detailed information regarding copyright policies, please visit the JKSI Copyright Notice page at: https://journal.stikessuakainsan.ac.id/index.php/jksi/CopyrightNotice

Article Processing Charges

Information on any applicable article processing charges, if any, is published on the journal website and is not duplicated here to avoid inconsistency between documents.

Archiving

Published articles are archived by the journal's hosting platform in accordance with its standard digital preservation practices.

14. Submission Checklist

As part of the submission process, authors must confirm that their submission complies with each of the following items. Submissions that do not comply may be returned to the authors before review.

  • The manuscript is original, has not been previously published, and is not under consideration elsewhere; any related preprint has been disclosed (Sections 2.1–2.2).
  • The submission file is in Microsoft Word (.docx) or OpenDocument (.odt) format and uses the JKSI Manuscript Template.
  • The manuscript follows the structure and reporting guideline appropriate to its article type (Sections 3–4).
  • The title page includes all required elements (Section 5.2), including ORCID iDs where available.
  • The abstract is structured, within the word limit, and provided in both English and Bahasa Indonesia (Section 5.3).
  • No information, photograph, or other identifying detail discloses the identity of a study participant without documented written consent (Section 2.5).
  • For research involving human participants, ethical approval details (or a justification for its absence) are stated in the manuscript, consistent with the Declaration of Helsinki (Section 2.4); for animal research, applicable institutional/national guidelines have been followed.
  • Any previously published photographs, figures, or tables have been reproduced with permission from the original copyright holder, and the source is acknowledged.
  • A completed reporting-guideline checklist (e.g., STROBE, CONSORT, COREQ, PRISMA 2020, CARE) appropriate to the study design is attached, where applicable (Section 4).
  • A Conflict of Interest declaration and completed ICMJE disclosure form are provided for each author (Section 5.13).
  • A Funding statement is included (Section 5.12).
  • A Data Availability Statement is included (Section 5.14).
  • A CRediT author contribution statement is included and has been approved by all authors (Section 5.15).
  • Statistical reporting follows Section 7 (effect estimates with 95% CI, exact p-values).
  • References follow APA 7th Edition and the guidance in Section 8.
  • Any substantive use of AI tools in preparing the manuscript has been disclosed (Section 10).
  • The completed Author's Statement / Conflict of Interest form, signed by all authors, is attached.

15. Templates and Supplementary Files

The following documents accompany these Guidelines and are available from the journal website / editorial office. Authors should ensure they are using the current version of each document:

Each Manuscript Template is a format-oriented working document only: it should contain no explanatory text about scientific writing theory or editorial policy. All policy explanations reside in these Guidelines, so that the Template can remain a short, practical document authors complete directly using the built-in JKSI paragraph styles.

16. Privacy Statement

Names and email addresses entered on this journal's website will be used exclusively for the stated purposes of this journal including manuscript handling, peer review, editorial communication, and publication metadata and will not be made available for any other purpose or to any other party. This applies equally to data collected from authors and from reviewers. Where third-party services (e.g., plagiarism-checking software, ORCID, DOI registration agencies) are used as part of manuscript handling, only the minimum necessary information is shared with those services for that purpose.